Filter
Showing 13–24 of 29 results
-
-
-
Melanotan 1, a synthetic analogue derived from alphamelanocyte stimulating hormone, is clinically utilized in
Europe to prevent sun-induced skin damage, particularly
phototoxicity, in individuals affected by erythropoietic
protoporphyria. Initially formulated as a sunless tanning
solution, Melanotan 1 exhibits various physiological effects
on blood pressure, feeding patterns, central nervous
system functionality, and more. Currently, the peptide is
undergoing phase 3 clinical trials for treating polymorphose
light eruption and is in phase 2 trials for managing actinic
keratosis—a specific sun-induced skin damage
condition—and its severe variant, squamous cell
carcinoma.
$40.00
-
-
-
PT-141, known as bremelanotide, has earned the
nickname “female Viagra” due to its past exploration in
phase IIb human clinical trials for managing female
hypoactive sexual desire disorder (HSDD). This peptide,
categorized as a melanocortin, primarily targets the
melanocortin 4 receptor (MC-4R) and MC-1R. Additionally,
in 2009, investigations into PT-141 extended to its
potential application in addressing acute hemorrhage.
Derived from another synthetic melanocortin, melanotan 2
(MT-2), PT-141 has garnered attention for its multifaceted
research applications beyond its initial link to sexual desire
disorder in women.
$50.00
-
-
Selank, originating from Russia, stands as a brief peptide
possessing both nootropic and anxiolytic attributes.
Serving as a synthetic counterpart to the naturally existing
Tuftsin, an immunomodulatory peptide, Selank mirrors
Tuftsin closely, differing mainly by containing an additional
four amino acids in its chain. This modification aids in
enhancing its metabolic stability and extending its half-life.
Notably, Selank, like Tuftsin, influences IL-6, T helper cells,
monoamine neurotransmitters, and brain-derived
neurotrophic factor (BDNF). The fundamental similarities
between Selank and Tuftsin lie in their structure, with
Selank’s slight alteration in amino acids contributing to
improved stability and longevity.
Clinical trials have explored Selank’s potential application
as a treatment for generalized anxiety disorder.
$50.00
-
Semaglutide, derived from the naturally occurring GLP-1
peptide, is renowned for its ability to lower blood sugar
levels and enhance insulin secretion. Emerging research
indicates that Semaglutide may not only improve heart,
liver, and lung function but also potentially mitigate or
prevent the effects of Alzheimer’s disease. Furthermore,
Semaglutide has demonstrated a substantial reduction in
appetite by delaying gastric emptying and decreasing
intestinal motility. This GLP-1 analog has proven efficacy in
stimulating insulin and suppressing glucagon secretion in a
glucose-dependent manner.
$155.00
-
Hailing from Russia, Semax has demonstrated its efficacy
in diverse scenarios such as stroke, cognitive impairment,
dementia, and inflammation of the optic nerve. Beyond
these applications, it has undergone evaluation as a
prospective immune system enhancer and exhibited
antidepressant and anxiolytic properties. Studies have
highlighted Semax’s capability to elevate levels of brainderived neurotrophic factor (BDNF) within the central
nervous system, along with increased levels of serotonin
and dopamine.
$65.00
-
-